Wayne Rycroft

An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

Gerard R. Dawson, Karen Maubach, Neil Collinson et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 240 citations

Postponement of Satiety by Blockade of Brain Cholecystokinin (CCK-B) Receptors

Colin T. Dourish, Wayne Rycroft, S.D. Iversen · Science · 1989 · 239 citations

Synaptic Transmission, Food Intake, Satiety Research +18

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

F.D. Tattersall, Wayne Rycroft, B. Francis et al. · Neuropharmacology · 1996 · 211 citations

Signal Transduction, Signaling Pathway, Medicine +6

Structural Optimization Affording 2-(<i>R</i>)-(1-(<i>R</i>)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(<i>S</i>)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss et al. · Journal of Medicinal Chemistry · 1998 · 203 citations · Full text

Orally Active, Pharmacotherapy, Pharmaceutical Chemistry +21

The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

F.D. Tattersall, Wayne Rycroft, M. Cumberbatch et al. · Neuropharmacology · 2000 · 136 citations

Molecular Pharmacology, Signaling Pathway, Cisplatin-induced Emesis +7